C5E-14049-40020
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 019 / MA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
- 2021-01-13
- 2021-01-17
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-21
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms, Sensitive skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Leg cramps, skin sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-11
- 2021-02-20
- 2021-02-25
- 2021-03-04
- 2021-04-22
- 2021-07-22
-
2021-11-02
Dose 3 — Pfizer-BioNTech
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-25
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2022-02-03
- 2022-05-03
-
2022-11-02
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous, Hypothyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hypothyroid, miscarriage.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-02
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-02 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Leg cramps, skin sensitivity
Release 12 — 12 months, dose 3
Symptoms: Hypothyroid, miscarriage.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release